Evaluation of the Potential Utility of the Total Thrombus-Formation Analysis System in Comparison to the Platelet Function Analyser in Subjects With Primary Haemostatic Defects
| No. | 65 |
|---|---|
| Citation | Br J Haematol 191(1), e7-e10(2020) |
| Institute | CHU de Bordeaux |
| 1st Author | J Charpy |
| AR | |
| PL | 〇(T-TAS01) |
| HD | |
| Paper types | Clinical study |
| Main purpose | Evaluation of sensitivity and specificity of T-TAS PL assay in comparison with PFA-200 (CEPI) |
| Disease | VWD and/or platelet function disorders(PFD) |
| Antiplatelet drug | - |
| Anticoagulant drug | - |
| Other drug | - |
| Clinical specimens | |
| Animal | - |
| Keyword | platelet function analyser, platelet function disorder, primary haemostatic defect, total thrombus-formation analysis system, von Willebrand disease |